The Effect of GCSF in the Treatment of ALS Patients

Clinical trial NCT01825551 · COMPLETED

Trial details

NCT number: NCT01825551
Sponsor: Tehran University of Medical Sciences
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2012-11-01
Primary completion: 2013-11-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.